The report entitled “Brazil Generic Drug Market – Industry Trends, Competitive Landscape, Opportunities and Outlook” represents an in-depth analysis on the historical, current and future trends in the generic drug market in Brazil. Read full report click here: http://www.imarcgroup.com/brazil-generic-drug-market

1. Imarc
www.imarcgroup.com
Consulting Services
Copyright © 2016 International Market Analysis Research & Consulting (IMARC). All Rights Reserved
Brazil Generic Drug
Market – Industry
Trends, Competitive
Landscape,
Opportunities and
Outlook

2. The International Market Analysis Research and Consulting Group is a leading advisor on management
strategy and market research worldwide. We partner with clients in all sectors and regions to identify
their highest-value opportunities, address their most critical challenges, and transform their
businesses.
IMARC’s information products include major market, scientific, economic and technological
developments for business leaders in pharmaceutical, industrial, and high technology organizations.
Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food
and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the
company’s expertise.
IMARC’s tailored approach combines unfathomable insight into the dynamics of companies and
markets with close cooperation at all levels of the client organization. This ensures that our clients
achieve unmatchable competitive advantage, build more proficient organizations, and secure lasting
results.
Report DescriptionAbout IMARC Group
Imarc
www.imarcgroup.com

3. Report DescriptionReport Description and Highlights
Imarc
www.imarcgroup.com
Brazil Generic Drug Market – Industry Trends, Competitive Landscape, Opportunities and Outlook
Since the introduction of generic drugs in 2001, Brazil’s pharmaceutical industry has undergone a
transformation. Generic drugs have been continuously gaining market share and currently account
for a significant share of the total pharmaceutical market in Brazil. According to estimates, around
BRL 2 Billion worth of branded drugs are expected to lose patent protection during the next five
years. The high potential of generic drugs is also driven by the fact that despite strong growth in
recent years, the penetration of generics still remains low compared to mature markets such as
Germany, the United States, the United Kingdom, etc. These factors along with a rising ageing
population, increasing prevalence of life style diseases and the significant cost savings achieved from
the use of generic drugs are expected to drive this market during the next five years.
The report entitled “Brazil Generic Drug Market – Industry Trends, Competitive Landscape,
Opportunities and Outlook” represents an in-depth analysis on the historical, current and future
trends in the generic drug market in Brazil. This research report serves as an exceptional tool to
understand the drivers, sales trends, volume trends, market structure, competitive landscape,
regulations, key players, manufacturing and the outlook of generic drugs in Brazil. This report can
serve as an excellent guide for investors, researchers, consultants, marketing strategists and all those
who want to gain an insight into the market for generic drugs in Brazil.

4. Report DescriptionReport Description and Highlights
Imarc
www.imarcgroup.com
Key Questions Answered:
• What are generic drugs, how are they different from branded drugs?
• How has the generic drug market performed in recent years?
• How have generics performed compared to branded drugs?
• What were the total sales and volumes of generic drugs in Brazil?
• Who are the key players in Brazil generic drug market?
• What is the structure of the generic drug market in Brazil?
• What is the pricing mechanism of generic drugs in Brazil?
• What is the value chain of generic drugs in Brazil?
• What are the regulations for generic drugs in Brazil?
• How are generic drugs distributed in Brazil?
• How are generic drugs manufactured?
• What are the drivers and challenges in the generic drugs market in Brazil?
Table of Contents
1 Research Methodology and Market Definitions
2 Report Summary
3 Brazil Generic Drug Market – Introduction
3.1 What are Generic Drugs?

5. Report DescriptionReport Description and Highlights
Imarc
www.imarcgroup.com
4 Why is the Brazil Generic Drug Market so Lucrative
4.1 Drug Patent Expiries
4.2 Lower Costs
4.3 Government Support
4.4 Increasing Consumer Confidence
4.5 Increasing Access to Generic Drugs
4.6 High Growth Potential for Biosimilar Drugs
5 Global Generic Drug Market
5.1 Current and Historical Market Trends
5.2 Market Breakup by Country
5.3 Most Prescribed Generic and Branded Drugs
5.4 Market Forecast
6 Brazil Generic Drug Market
6.1 Brazil Pharmaceutical Market: Current, Historical and Future Market Trends
6.2 Brazil Pharmaceutical Market: Share of Branded and Generic Drugs
6.3 Brazil Generic Drug Market: Current, Historical and Future Sales Trends
6.4 Brazil Generic Drug Market: Current, Historical and Future Volume Trends
7 Brazil Generic Drug Market: Competitive Landscape
7.1 Brazil Generic Drug Market: Competitive Structure
7.2 Brazil Generic Drug Market: Market Share of Key Players
7.3 Distribution Channels

6. Report DescriptionReport Description and Highlights
Imarc
www.imarcgroup.com
8 Brazil Generic Drug Market- Value Chain Analysis
8.1 Research and Development
8.2 Manufacturing
8.3 Marketing
8.4 Distribution
8.5 Pricing
9 Government Policy
10 Brazil Generic Drug Market: Key Success Factors
11 Brazil Generic Drug Market: Road Blocks
12 Requirements for Setting Up a Generic Drug Manufacturing Plant
12.1 Manufacturing Process
12.2 Raw Material Requirements
12.3 Machinery and Infrastructure Requirements
13 Brazil Generic Drug Market: Key Company Profiles
13.1 EMS S.A.
13.2 Sanofi Group
13.3 Eurofarma Laboratórios S.A.
13.4 Hypermarcas S.A.
13.5 Sandoz
13.6 Ache Laboratories
13.7 União Química Farmacêutica Nacional S.A.

7. Report DescriptionReport Description and Highlights
Imarc
www.imarcgroup.com
List of Figures
Figure 3 1: Structure of the Pharmaceutical Industry
Figure 3 2: Classification of Drugs
Figure 5 1: Global: Generic Drug Market: Sales Value (in Billion US$), 2010-2015
Figure 5 2: Global: Generic Drug Market: Sales Volume (in Billion SU), 2010-2015
Figure 5 3: Global: Generic Drug Market: Sales Value Breakup by Country (in %), 2015
Figure 5 4: Global: Generic Drug Market: Sales Volume Breakup by Country (in %), 2015
Figure 5 5: Global: Generic Drug Market Forecast: Sales Value (in Billion US$), 2016-2021
Figure 5 6: Global: Generic Drug Market Forecast: Sales Volume (in Billion Units), 2016-2021
Figure 6 1: Brazil: Pharmaceutical Market: Sales Value (in Billion US$), 2010-2015
Figure 6 2: Brazil: Pharmaceutical Market: Sales Volume (in Billion Units), 2010-2015
Figure 6 3: Brazil: Pharmaceutical Market Forecast: Sales Value (in Billion US$), 2016-2021
Figure 6 4: Brazil: Pharmaceutical Market Forecast: Sales Volume (in Billion Units), 2016-2021
Figure 6 5: Brazil: Pharmaceutical Market: Sales Volume Breakup of Branded and Generic Drugs (in
%), 2010 and 2015
Figure 6 6: Brazil: Pharmaceutical Market: Sales Value Breakup of Branded and Generic Drugs (in
%), 2010 and 2015
Figure 6 7: Brazil: Generic Drug Market: Sales Value (in Billion US$), 2010-2015
Figure 6 8: Brazil: Generic Drug Market Forecast: Sales Value (in Billion US$), 2016-2021
Figure 6 9: Brazil: Generic Drug Market: Sales Volume (in Billion Units), 2010-2015

8. Report DescriptionReport Description and Highlights
Imarc
www.imarcgroup.com
Figure 6 10: Brazil: Generic Drug Market Forecast: Sales Volume (in Billion Unit), 2016-2021
Figure 7 1: Brazil: Generic Drug Market: Sales Share of Top Players (in %), 2015
Figure 7 2: Brazil: Generic Drug Market: Number of Companies Producing Generic Drugs (in Units),
2010-2015
Figure 7 3: Brazil – Number of Pharmacies and Drug Stores, 2009 -2015
Figure 7 4: Brazil – Region-Wise Drug Sales Value (in %), 2009 -2015
Figure 7 5: Brazil – Channel-Wise Market Share by Number of Stores, 2009 -2015
Figure 7 6: Brazil – Channel-Wise Market Share by Sales Value (in %), 2009 -2015
Figure 8 1: Brazil – Generic Drug Market – Value Chain Analysis
List of Tables
Table 4 1: Brazil: Sales (in Billion US$) and Patent Expiry of Major Drugs Expected to Lose Patent
Protection
Table 5 1: Global – Generic Drug Market: Sales Volume and Growth of Major Markets, 2015
Table 5 2: Global: Generic Drug Market: Volume Performance of Top Generic Drugs (in Million
Prescriptions), 2015
Table 5 3: Global: Branded Drugs Market: Volume Performance of Top Branded Drugs (in Million
Prescriptions), 2015

9. Report DescriptionReport Description and Highlights
Imarc
www.imarcgroup.com
To buy the complete report or to get a free sample, please contact:
IMARC Group Asia:
Email: apac@imarcgroup.com
Phone: +91-120-415-5099
IMARC Group North America:
Email: america@imarcgroup.com
Phone: +1-631-791-1145
IMARC Group Europe, Middle East & Africa:
Email: ema@imarcgroup.com
Phone: +44-702-409-7331
To know more please visit: http://www.imarcgroup.com/brazil-generic-drug-market

10. Report DescriptionReport Description and Highlights
Imarc
www.imarcgroup.com
© 2016 IMARC All Rights Reserved
This Publication and all it’s contents unless otherwise mentioned are copyrighted in the name of
International Market Analysis Research and Consulting (IMARC). No part of this publication may be
reproduced, repackaged, redistributed or resold in whole or in any part. The publication may also not be
used in any form or by and means graphic electronic or mechanical, including photocopying, recording,
taping or by information storage or retrieval, or by any other form, without the express consent of
International Market Analysis Research and Consulting (IMARC).
Disclaimer: All contents and data of this publication, including forecasts, data analysis and opinion have been
based on information and sources believed to be accurate and reliable at the time of publishing.
International Market Analysis Research and Consulting makes no representation of warranty of any kind as to
the accuracy or completeness of any Information provided. IMARC accepts no liability whatsoever for any
loss or damage resulting from opinion, errors or inaccuracies if any found this publication.
IMARC, IMARC Group and Global Therapy Insight Series are registered trademarks of International Market
Analysis Research and Consulting. All other trademarks used in this publication are registered trademarks of
their respective companies.

11. FOR MORE DETAILS
Visit us at :
Stay With Us:
TELEPHONE: +91-120-4155099
E-MAIL: sales@imarcgroup.com
http://www.imarcgroup.com
Contact Us